ThruFlo Endovascular
PrivateLast Round
Seed
Jun 10, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ThruFlo Endovascular, Inc. is a medical device company that develops and markets advanced endovascular devices for the treatment of Branch Point Aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThruFlo Endovascular Comparables
Compare ThruFlo Endovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NV MedTech | 87% | |
| Oxford Endovascular | 82% | |
| Acandis | 78% |
ThruFlo Endovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 10, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
Completed a Seed funding round.
ThruFlo Endovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ThruFlo Endovascular's valuation, stock price, and market status.
Is ThruFlo Endovascular a public or private company?
ThruFlo Endovascular is a private company.
What is the current stock price of ThruFlo Endovascular?
ThruFlo Endovascular is a private company with no public stock price. No recent secondary market data is available.
How much is ThruFlo Endovascular worth (valuation)?
Valuation information for ThruFlo Endovascular is not publicly available.
Can I buy ThruFlo Endovascular stock?
ThruFlo Endovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ThruFlo Endovascular's last funding round?
ThruFlo Endovascular's most recent funding round was Seed on June 10, 2026.
Who are the main investors in ThruFlo Endovascular?
Investor information for ThruFlo Endovascular is not publicly disclosed.
Will ThruFlo Endovascular IPO soon?
No public IPO plans have been announced for ThruFlo Endovascular.
How can I track ThruFlo Endovascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ThruFlo Endovascular's secondary market activity and sign up for updates.